[HTML][HTML] Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
R Souza, DB Badesch, HA Ghofrani… - European …, 2023 - Eur Respiratory Soc
Background In the phase 3 STELLAR trial, sotatercept, an investigational first-in-class activin
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
[HTML][HTML] Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
R Souza, DB Badesch, HA Ghofrani… - The European …, 2023 - ncbi.nlm.nih.gov
Background In the phase 3 STELLAR trial, sotatercept, an investigational first-in-class activin
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.
R Souza, DB Badesch, HA Ghofrani… - The European …, 2023 - europepmc.org
Background In the phase 3 STELLAR trial, sotatercept, an investigational first-in-class activin
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
R Souza, D Badesch, HA Ghofrani, JSR Gibbs… - European Respiratory …, 2023 - hal.science
Background In the phase 3 STELLAR trial, sotatercept, an investigational first-in-class activin
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
R Souza, DB Badesch, HA Ghofrani… - The European …, 2023 - pubmed.ncbi.nlm.nih.gov
Background In the phase 3 STELLAR trial, sotatercept, an investigational first-in-class activin
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
R Souza, DB Badesch, HA Ghofrani… - European Respiratory …, 2023 - ppm.edu.pl
Streszczenie w języku oryginału Background In the phase 3 STELLAR trial, sotatercept, an
investigational first-in-class activin signalling inhibitor, demonstrated beneficial effects on 6 …
investigational first-in-class activin signalling inhibitor, demonstrated beneficial effects on 6 …
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
R SOUZA, DB BADESCH… - European …, 2023 - observatorio.fm.usp.br
Background In the phase 3 STELLAR trial, sotatercept, an investigational first-in-class activin
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
signalling inhibitor, demonstrated beneficial effects on 6-min walk distance and additional …
[引用][C] Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
R Souza, DB Badesch, HA Ghofrani, JSR Gibbs… - 2023 - ruj.uj.edu.pl
function: analysis of the STELLAR trial
R Souza, DB Badesch, HA Ghofrani, JSR Gibbs… - Eur Respir …, 2023 - Eur Respiratory Soc
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR
trial Page 1 Effects of sotatercept on haemodynamics and right heart function: analysis of the …
trial Page 1 Effects of sotatercept on haemodynamics and right heart function: analysis of the …
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
R Souza, DB Badesch, HA Ghofrani… - European Respiratory …, 2023 - ppm.edu.pl
Abstract in original language Background In the phase 3 STELLAR trial, sotatercept, an
investigational first-in-class activin signalling inhibitor, demonstrated beneficial effects on 6 …
investigational first-in-class activin signalling inhibitor, demonstrated beneficial effects on 6 …